Currently out of the existing stock ratings of Richard Vosser, 23 are a BUY (41.82%), 18 are a HOLD (32.73%), 14 are a SELL (25.45%).

Richard Vosser

Work Performance Price Targets & Ratings Chart

Analyst Richard Vosser, currently employed at JPMORGAN, carries an average stock price target met ratio of 60.95% that have a potential upside of 28.95% achieved within 425 days.

Richard Vosser’s has documented 97 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVS, Novartis AG ADR at 08-Dec-2025.

Wall Street Analyst Richard Vosser

Analyst best performing recommendations are on MOR (MORPHOSYS AG ADR).
The best stock recommendation documented was for MOR (MORPHOSYS AG ADR) at 12/5/2023. The price target of $8.5 was fulfilled within 6 days with a profit of $0.92 (12.14%) receiving and performance score of 20.23.

Average potential price target upside

of $64.05 (129.72%) on UCBJY (UCB SA ADR).
of $18.47 (27.7%) on NVS (NOVARTIS AG ADR).
of $11.12 (18.99%) on NVO (NOVO NORDISK A/S).

NVO Novo Nordisk A/S NVS Novartis AG ADR SNY Sanofi ADR RHHBY Roche Holding Ltd ADR UCBJY UCB SA ADR MOLN Molecular Partners AG ADR MOR MorphoSys AG ADR GSK GlaxoSmithKline PLC ADR

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Peter Verdult (CITI)